About The Medical Condition Drug Evaluation, FDA Phase II
Find the definition of the medical term Drug Evaluation, FDA Phase II. Drug Evaluation, FDA Phase II defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase II
| Drug Evaluation, FDA Phase II Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase II?
Studies that are usually controlled to assess the effectiveness and dosage (if appropriate) of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques. These studies are performed on several hundred volunteers, including a limited number of patients with the target disease or disorder, and last about two years. This concept includes phase II studies conducted in both the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Salamandridae ‐ A family of Urodela consisting of 15 living genera and about…
- Industry, Healthcare ‐ Economic sector concerned with the provision, distribution, and…
- Acquired Facial Neuropathy ‐ Diseases of the facial nerve or nuclei. Pontine disorders may…
- Neoplasms, Basal Cell ‐ Neoplasms composed of cells from the deepest layer of the epidermis.…
- Abdominal Pain ‐ Sensation of discomfort, distress, or agony in the abdominal…
- Meningitis, Meningococcic ‐ A fulminant infection of the meninges and subarachnoid fluid…
- Calcium Channel, R-Type ‐ CALCIUM CHANNELS located in the neurons of the brain. They are…
- Gla Protein, Bone ‐ Vitamin K-dependent calcium-binding protein synthesized by osteoblasts…
- Photosensitive Epilepsies ‐ A subtype of epilepsy characterized by seizures that are consistently…
- Diiodotyrosine Receptors ‐ Proteins, usually found in the nucleus, that specifically bind…